Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0648

+8.0%

Nov 11 3:24 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Khris Smith who wrote (12529)	11/22/2013 6:31:59 PM
From: Mammon	of 13111

Kris, for Googling purposes, try "chimeric antigen receptor" a more complete explanation of the trial. teawithmd.com From the New England Journal of Medicine, about the trial: nejm.org From Wikipedia. Note possibility of adverse events, including death. en.wikipedia.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next